IL229702A - אמצעים ושיטות לאימונותרפיה תאית פעילה של סרטן על ידי שימוש בתאי גידול המומתים על ידי לחץ הידרוסטטי גבוה ותאים דנדריטיים - Google Patents

אמצעים ושיטות לאימונותרפיה תאית פעילה של סרטן על ידי שימוש בתאי גידול המומתים על ידי לחץ הידרוסטטי גבוה ותאים דנדריטיים

Info

Publication number
IL229702A
IL229702A IL229702A IL22970213A IL229702A IL 229702 A IL229702 A IL 229702A IL 229702 A IL229702 A IL 229702A IL 22970213 A IL22970213 A IL 22970213A IL 229702 A IL229702 A IL 229702A
Authority
IL
Israel
Prior art keywords
tumor
cells
tumor cells
ceils
hydrostatic pressure
Prior art date
Application number
IL229702A
Other languages
English (en)
Other versions
IL229702A0 (he
Inventor
Bartunkova Jirina
Spisek Radek
Original Assignee
Sotio As
Bartunkova Jirina
Spisek Radek
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP11172622A external-priority patent/EP2543386A1/en
Application filed by Sotio As, Bartunkova Jirina, Spisek Radek filed Critical Sotio As
Publication of IL229702A0 publication Critical patent/IL229702A0/he
Publication of IL229702A publication Critical patent/IL229702A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL229702A 2011-07-05 2013-11-28 אמצעים ושיטות לאימונותרפיה תאית פעילה של סרטן על ידי שימוש בתאי גידול המומתים על ידי לחץ הידרוסטטי גבוה ותאים דנדריטיים IL229702A (he)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161504387P 2011-07-05 2011-07-05
EP11172622A EP2543386A1 (en) 2011-07-05 2011-07-05 Means and methods for active cellular immunotherapy of cancer by using tumor cells killed by high hydrostatic pressure
PCT/EP2012/062950 WO2013004708A1 (en) 2011-07-05 2012-07-04 Means and methods for active cellular immunotherapy of cancer by using tumor cells killed by high hydrostatic pressure and dendritic cells

Publications (2)

Publication Number Publication Date
IL229702A0 IL229702A0 (he) 2014-01-30
IL229702A true IL229702A (he) 2016-09-29

Family

ID=50023029

Family Applications (2)

Application Number Title Priority Date Filing Date
IL229702A IL229702A (he) 2011-07-05 2013-11-28 אמצעים ושיטות לאימונותרפיה תאית פעילה של סרטן על ידי שימוש בתאי גידול המומתים על ידי לחץ הידרוסטטי גבוה ותאים דנדריטיים
IL24778116A IL247781B (he) 2011-07-05 2016-09-12 אמצעים ושיטות לאימונותרפיה תאית פעילה של סרטן על ידי שימוש בתאי גידול המומתים על ידי לחץ הידרוסטטי גבוה ותאים דנדריטיים

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL24778116A IL247781B (he) 2011-07-05 2016-09-12 אמצעים ושיטות לאימונותרפיה תאית פעילה של סרטן על ידי שימוש בתאי גידול המומתים על ידי לחץ הידרוסטטי גבוה ותאים דנדריטיים

Country Status (7)

Country Link
JP (1) JP6235085B2 (he)
CL (1) CL2013003282A1 (he)
CY (1) CY1115803T1 (he)
HR (1) HRP20141230T1 (he)
IL (2) IL229702A (he)
MX (1) MX2013013243A (he)
ZA (1) ZA201307886B (he)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2768942T3 (da) 2011-10-17 2020-01-27 Massachusetts Inst Technology Intracellulær levering
KR102386122B1 (ko) 2013-08-16 2022-04-14 메사추세츠 인스티튜트 오브 테크놀로지 세포로의 선택적 물질 전달
KR102819064B1 (ko) 2014-10-31 2025-06-12 메사추세츠 인스티튜트 오브 테크놀로지 면역 세포로의 생체분자의 전달
CN107002089B (zh) 2014-11-14 2021-09-07 麻省理工学院 化合物和组合物向细胞中的破坏和场实现的递送
WO2016115179A1 (en) 2015-01-12 2016-07-21 Massachusetts Institute Of Technology Gene editing through microfluidic delivery
JP6925984B2 (ja) 2015-07-09 2021-08-25 マサチューセッツ インスティテュート オブ テクノロジー 無核細胞への物質の送達

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6602709B1 (en) * 1998-02-20 2003-08-05 The Rockefeller University Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells
US8420078B2 (en) * 2005-03-10 2013-04-16 Yeda Research And Development Co. Ltd. Methods and immunogenic cell preparations for treating antigen-associated diseases

Also Published As

Publication number Publication date
MX2013013243A (es) 2014-05-30
CL2013003282A1 (es) 2014-10-10
JP2017025066A (ja) 2017-02-02
IL247781A0 (he) 2016-11-30
CY1115803T1 (el) 2017-01-25
JP6235085B2 (ja) 2017-11-22
IL247781B (he) 2019-11-28
IL229702A0 (he) 2014-01-30
ZA201307886B (en) 2015-03-25
HRP20141230T1 (hr) 2015-02-13

Similar Documents

Publication Publication Date Title
AU2016234915B2 (en) Means and methods for active cellular immunotherapy of cancer by using tumor cells killed by high hydrostatic pressure and dendritic cells
AU2012280322A1 (en) Means and methods for active cellular immunotherapy of cancer by using tumor cells killed by high hydrostatic pressure and dendritic cells
US10918704B2 (en) Means and methods for active cellular immunotherapy of cancer by using tumor cells killed by high hydrostatic pressure and dendritic cells
JP6134763B2 (ja) ＧＭ−ＣＳＦ及びインターフェロンαを用いて生成され、且つ熱処理され死滅したがん細胞を取り込んだ樹状細胞
JP6235085B2 (ja) 高静水圧によって死滅させた腫瘍細胞および樹状細胞を用いた活性細胞癌免疫療法のための手段および方法
US20130129713A1 (en) Method of antigen loading for immunotherapy
Su et al. Anti-tumor efficacy of a hepatocellular carcinoma vaccine based on dendritic cells combined with tumor-derived autophagosomes in murine models
Lemoine et al. Massive expansion of regulatory T-cells following interleukin 2 treatment during a phase I-II dendritic cell-based immunotherapy of metastatic renal cancer
Shan et al. Cytokine-induced killer cells co-cultured with dendritic cells loaded with the protein lysate produced by radiofrequency ablation induce a specific antitumor response
Baek et al. Dendritic cell (DC) vaccine in mouse lung cancer minimal residual model; comparison of monocyte-derived DC vs. hematopoietic stem cell derived-DC
Radej et al. Immunomodelling characteristics of mature dendritic cells stimulated by colon cancer cells lysates
NZ618000B2 (en) Means and methods for active cellular immunotherapy of cancer by using tumor cells killed by high hydrostatic pressure and dendritic cells
HK1177693A (en) Means and methods for active cellular immunotherapy of cancer by using tumor cells killed by high hydrostatic pressure and dendritic cells
HK40009906A (zh) 使用树突细胞和由高静水压力杀死的肿瘤细胞对癌症进行主动细胞免疫治疗的手段和方法
HK1190920B (en) Means and methods for active cellular immunotherapy of cancer by using tumor cells killed by high hydrostatic pressure and dendritic cells
HK1190920A (en) Means and methods for active cellular immunotherapy of cancer by using tumor cells killed by high hydrostatic pressure and dendritic cells

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed